Nov 2 (Reuters) - Raysearch Laboratories Ab (Publ) says:
* Has been chosen as the treatment planning system for the CYCLHAD Hadrontherapy Center, located in Caen, France.
* CYCLHAD will deliver proton therapy treatments via IBA’s ProteusOne compact system, with the first patient treatment scheduled to take place in June.
* A further phase of expansion is planned for the center, including the installation of the NHa C400 cyclotron system to enable research with carbon ions. Source text for Eikon: Further company coverage: (Reporting By Johan Sennero)